Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Conley

Showing results (531-540 of 563) with videos related to

Pageof 57
Sort By:
Cancer Research Communications|May 21, 2026
Drug screening of sarcoma cells: finding shared sensitivitiesHannah C Beird, Carl Ho, Roberto Cardenas-Zuniga, et al.
ESMO Open|March 15, 2021
Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I studyT Cascone, R L Sacks, I M Subbiah, et al.
The Journal of Biological Chemistry|June 28, 2014
Inhibition of plasma kallikrein by a highly specific active site blocking antibodyJon A Kenniston, Ryan R Faucette, Diana Martik, et al.
Science (New York, N.Y.)|February 27, 2025
Too much of a good thing: Lessons from compromised rootworm Bt maize in the US Corn BeltZiwei Ye, Christina DiFonzo, David A Hennessy, et al.
Cancers|May 11, 2024
High-Grade Pleomorphic Sarcomas Treated with Immune Checkpoint Blockade: The MD Anderson Cancer Center ExperienceLewis F Nasr, Marianne Zoghbi, Rossana Lazcano, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2026
A pooled analysis of phase 2 clinical trials in advanced chordomaGregory M Cote, Corrine F Elliott, Astrid Lipplaa, et al.
Neuro-Oncology|March 8, 2026
Oncolytic Adenoviral Infection of Chordoma Achieves Treatment Efficacy Associated with Immunologic Response and Tumor Microenvironmental AlterationXizi Wu, Daniel Ledbetter, Jen-Wei Tsai, et al.
Molecular Cancer Therapeutics|April 1, 2024
Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient LeiomyosarcomasMichael S Nakazawa, Ian M Silverman, Victoria Rimkunas, et al.
Cancer|July 6, 2022
Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort studyVinod Ravi, Aparna Subramaniam, Jing Zheng, et al.
Nature Communications|February 22, 2020
Immuno-genomic landscape of osteosarcomaChia-Chin Wu, Hannah C Beird, J Andrew Livingston, et al.
Pageof 57

Showing results (531-540 of 563) with videos related to

Sort By:
Pageof 57
Cancer Research Communications|May 21, 2026
Drug screening of sarcoma cells: finding shared sensitivitiesHannah C Beird, Carl Ho, Roberto Cardenas-Zuniga, et al.
ESMO Open|March 15, 2021
Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I studyT Cascone, R L Sacks, I M Subbiah, et al.
The Journal of Biological Chemistry|June 28, 2014
Inhibition of plasma kallikrein by a highly specific active site blocking antibodyJon A Kenniston, Ryan R Faucette, Diana Martik, et al.
Science (New York, N.Y.)|February 27, 2025
Too much of a good thing: Lessons from compromised rootworm Bt maize in the US Corn BeltZiwei Ye, Christina DiFonzo, David A Hennessy, et al.
Cancers|May 11, 2024
High-Grade Pleomorphic Sarcomas Treated with Immune Checkpoint Blockade: The MD Anderson Cancer Center ExperienceLewis F Nasr, Marianne Zoghbi, Rossana Lazcano, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2026
A pooled analysis of phase 2 clinical trials in advanced chordomaGregory M Cote, Corrine F Elliott, Astrid Lipplaa, et al.
Neuro-Oncology|March 8, 2026
Oncolytic Adenoviral Infection of Chordoma Achieves Treatment Efficacy Associated with Immunologic Response and Tumor Microenvironmental AlterationXizi Wu, Daniel Ledbetter, Jen-Wei Tsai, et al.
Molecular Cancer Therapeutics|April 1, 2024
Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient LeiomyosarcomasMichael S Nakazawa, Ian M Silverman, Victoria Rimkunas, et al.
Cancer|July 6, 2022
Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort studyVinod Ravi, Aparna Subramaniam, Jing Zheng, et al.
Nature Communications|February 22, 2020
Immuno-genomic landscape of osteosarcomaChia-Chin Wu, Hannah C Beird, J Andrew Livingston, et al.
Pageof 57